Tag Archives: Nobel Prize

Guest Blogspot – The UK Needs More Biotechnology Companies

Posted on May 17, 2011 by Barbara Arzymanow

The success of US biotechnology companies contrasts sharply with the disappointment in other countries. British companies valued by stock markets at more than about US $ 4 billion go in the FTSE 100 index. There are no biotechnology companies big … Continue reading →

Posted in Business, Drugs, Emerging technologies, Finance, Genetics, Pharma, Policy, Research, Technology | Tagged , , , , , , , , , , , , , , , , , , , | 1 Comment